This article explores the unique logistics and supply chain challenges of cell and gene therapy development and the future potential of this innovative sector.
the success of CGT depends on a robust and reliable supply chain”
Cell and gene therapies (CGT) offer a revolutionary approach to the treatment, prevention and potential cure of diseases. These advanced medical treatments provide hope for patients suffering from conditions that have historically been poorly understood and widely considered incurable, including genetic diseases and cancers. A recent survey1 of healthcare industry professionals showed that CGT is expected to have the most significant impact on the pharmaceutical industry in 2024. However, the success of CGT depends on a robust and reliable supply chain, which is a sensitive logistical challenge for the global scientific community.
Explore innovative, purpose-built AI solutions that elevate compliance and efficiency in quality and manufacturing operations.
17 September 2025 | 10:00 AM BST | FREE Webinar
In this webinar, find out how AI tools such as customised large language models (LLMs), orchestrated services, and human-in-the-loop design can streamline processes, enhance training, and improve efficiencies.
The CGT supply chain presents unique challenges, from regulatory compliance and temperature and time control to customs clearance and security”
Cell and gene therapies are fragile, invaluable, and potentially lifesaving. Such complex medical treatments demand a specialised approach to logistics, as any disruption to the supply chain could compromise treatments and risk the lives of patients.
The CGT supply chain presents unique challenges, from regulatory compliance and temperature and time control to customs clearance and security.
“The critical nature of these treatments, many of which can transform or even save the lives of patients, adds to the challenge, meaning that a personalised logistics solution is crucial,” says Anton James, Cell and Gene Therapies Logistics Specialist at Biocair.
He outlines five key challenges in the CGT supply chain including:
Regulatory compliance: The supply chain must comply with the complex regulations governing the transport of CGT materials, including GDP and IATA requirements. This also includes the completion of critical shipping paperwork.
Temperature and time: CGT materials are often time-and-temperature sensitive, and their viability is vulnerable to fluctuations in schedule or conditions. Strict temperature and time control must be maintained at all stages of the supply chain, including handover, transit and within the clinical setting.
Customs clearance: Cross-border shipping can be subject to delays at customs. Preventative measures should be implemented to reduce any potential delays which could prove disastrous for patients.
Communication and coordination: A successful supply chain relies on clear and straightforward communication. All parties involved must strictly adhere to instructions, and clear communication makes this much easier to manage.
Security and chain of custody (COC): Robust security measures can prevent the risk of crucial CGT materials being compromised in any way. Appropriate measures should be taken to maintain security throughout the supply chain and ensure the chain of custody always remains intact.
Trends in the CGT supply chain
The global CGT supply chain and logistics market is expected to reach $3.12 billion by 2031, having been valued at $1.23 billion in 2022.2
“In this new era of medicine, when tailored therapies are being developed to target individual cases of disease, the potential for CGT is almost limitless. As more organisations home in on promising therapies, there’s lots to be excited about,” says James.
“CGT is still very much in its discovery phase, so it is important that those in the supply chain keep up to date with emerging therapies and evolving logistical demands. As CGT revolutionises medicine, it is spurring change in the sector too, and logistics becomes ever-more crucial to the health and wellbeing of patients,” he reflects.
Artificial intelligence (AI) could also play a part in the future of the [CGT supply chain], however its application in the sector is not imminent”
Scalability is another factor that will define the logistics landscape in 2024 and beyond. “Existing life sciences supply chains need to be upscaled at all stages to cope with increasing demand,” says James.
“However, it is important to balance scalability with personalised solutions. Just as cell and gene therapies can be tailored to an individual patient, the supply chain also needs to be tailored to individual requirements.”
Artificial intelligence (AI) could also play a part in the future of the sector, however its application is not imminent. “The personalised nature of the industry means that AI is yet to have a tangible impact. It is essential that we retain the human side of our work to meet the specific needs of each patient and therapy,” notes James.
“With the rapid development of AI, the sector will inevitably change, but this must happen gradually so any new technology can be rigorously assessed and carefully integrated into the supply chain,” he adds.
A promising future for the CGT supply chain
Cell and gene therapy heralds a new age of medicine which promises life-changing, potentially lifesaving results for patients around the world. As momentum around CGT continues to grow through greater investment and innovation, partners working with the sector are also seeing increased opportunities for growth despite the unique challenges of life sciences.
A robust, adaptable supply chain might not grab the headlines in the way that an innovative new treatment might. But it is key to getting these treatments to the patients that need them, safely, securely and on time.
Cell and Gene Therapy Supply Chain/Logistics Market Size, Share & Trends Analysis Report By Application area, By Type of software solution, By Mode of Deployment, By End-user (Biobank, Cell therapy lab, Hospital, Research institute, Commercial organization) , By Region, And By Segment Forecasts, 2024-2031. [Internet] InsightAce Analytic Pvt. Ltd. 2024. [cited 2024May]. Available from: https://www.insightaceanalytic.com/report/cell-and-gene-therapy-supply-chain-logistics-market/1694
This website uses cookies to enable, optimise and analyse site operations, as well as to provide personalised content and allow you to connect to social media. By clicking "I agree" you consent to the use of cookies for non-essential functions and the related processing of personal data. You can adjust your cookie and associated data processing preferences at any time via our "Cookie Settings". Please view our Cookie Policy to learn more about the use of cookies on our website.
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorised as ”Necessary” are stored on your browser as they are as essential for the working of basic functionalities of the website. For our other types of cookies “Advertising & Targeting”, “Analytics” and “Performance”, these help us analyse and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these different types of cookies. But opting out of some of these cookies may have an effect on your browsing experience. You can adjust the available sliders to ‘Enabled’ or ‘Disabled’, then click ‘Save and Accept’. View our Cookie Policy page.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Cookie
Description
cookielawinfo-checkbox-advertising-targeting
The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Advertising & Targeting".
cookielawinfo-checkbox-analytics
This cookie is set by GDPR Cookie Consent WordPress Plugin. The cookie is used to remember the user consent for the cookies under the category "Analytics".
cookielawinfo-checkbox-necessary
This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance
This cookie is set by GDPR Cookie Consent WordPress Plugin. The cookie is used to remember the user consent for the cookies under the category "Performance".
PHPSESSID
This cookie is native to PHP applications. The cookie is used to store and identify a users' unique session ID for the purpose of managing user session on the website. The cookie is a session cookies and is deleted when all the browser windows are closed.
viewed_cookie_policy
The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
zmember_logged
This session cookie is served by our membership/subscription system and controls whether you are able to see content which is only available to logged in users.
Performance cookies are includes cookies that deliver enhanced functionalities of the website, such as caching. These cookies do not store any personal information.
Cookie
Description
cf_ob_info
This cookie is set by Cloudflare content delivery network and, in conjunction with the cookie 'cf_use_ob', is used to determine whether it should continue serving “Always Online” until the cookie expires.
cf_use_ob
This cookie is set by Cloudflare content delivery network and is used to determine whether it should continue serving “Always Online” until the cookie expires.
free_subscription_only
This session cookie is served by our membership/subscription system and controls which types of content you are able to access.
ls_smartpush
This cookie is set by Litespeed Server and allows the server to store settings to help improve performance of the site.
one_signal_sdk_db
This cookie is set by OneSignal push notifications and is used for storing user preferences in connection with their notification permission status.
YSC
This cookie is set by Youtube and is used to track the views of embedded videos.
Analytics cookies collect information about your use of the content, and in combination with previously collected information, are used to measure, understand, and report on your usage of this website.
Cookie
Description
bcookie
This cookie is set by LinkedIn. The purpose of the cookie is to enable LinkedIn functionalities on the page.
GPS
This cookie is set by YouTube and registers a unique ID for tracking users based on their geographical location
lang
This cookie is set by LinkedIn and is used to store the language preferences of a user to serve up content in that stored language the next time user visit the website.
lidc
This cookie is set by LinkedIn and used for routing.
lissc
This cookie is set by LinkedIn share Buttons and ad tags.
vuid
We embed videos from our official Vimeo channel. When you press play, Vimeo will drop third party cookies to enable the video to play and to see how long a viewer has watched the video. This cookie does not track individuals.
wow.anonymousId
This cookie is set by Spotler and tracks an anonymous visitor ID.
wow.schedule
This cookie is set by Spotler and enables it to track the Load Balance Session Queue.
wow.session
This cookie is set by Spotler to track the Internet Information Services (IIS) session state.
wow.utmvalues
This cookie is set by Spotler and stores the UTM values for the session. UTM values are specific text strings that are appended to URLs that allow Communigator to track the URLs and the UTM values when they get clicked on.
_ga
This cookie is set by Google Analytics and is used to calculate visitor, session, campaign data and keep track of site usage for the site's analytics report. It stores information anonymously and assign a randomly generated number to identify unique visitors.
_gat
This cookies is set by Google Universal Analytics to throttle the request rate to limit the collection of data on high traffic sites.
_gid
This cookie is set by Google Analytics and is used to store information of how visitors use a website and helps in creating an analytics report of how the website is doing. The data collected including the number visitors, the source where they have come from, and the pages visited in an anonymous form.
Advertising and targeting cookies help us provide our visitors with relevant ads and marketing campaigns.
Cookie
Description
advanced_ads_browser_width
This cookie is set by Advanced Ads and measures the browser width.
advanced_ads_page_impressions
This cookie is set by Advanced Ads and measures the number of previous page impressions.
advanced_ads_pro_server_info
This cookie is set by Advanced Ads and sets geo-location, user role and user capabilities. It is used by cache busting in Advanced Ads Pro when the appropriate visitor conditions are used.
advanced_ads_pro_visitor_referrer
This cookie is set by Advanced Ads and sets the referrer URL.
bscookie
This cookie is a browser ID cookie set by LinkedIn share Buttons and ad tags.
IDE
This cookie is set by Google DoubleClick and stores information about how the user uses the website and any other advertisement before visiting the website. This is used to present users with ads that are relevant to them according to the user profile.
li_sugr
This cookie is set by LinkedIn and is used for tracking.
UserMatchHistory
This cookie is set by Linkedin and is used to track visitors on multiple websites, in order to present relevant advertisement based on the visitor's preferences.
VISITOR_INFO1_LIVE
This cookie is set by YouTube. Used to track the information of the embedded YouTube videos on a website.